Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;52(11):1252-1253.
doi: 10.1016/j.dld.2020.09.020. Epub 2020 Oct 10.

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

Fabiana Zingone  1 , Andrea Buda  2 , Edoardo Savarino  3
Affiliations
Comment

Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice

Fabiana Zingone et al. Dig Liver Dis. 2020 Nov.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Zingone F., Buda A., Savarino E.V. Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Dig Liver Dis. 2020;52(6):604–605. - PMC - PubMed
    1. Prentice R.E., Ani A.H.A., Johnson D., Bond K., Christensen B. Asymptomatic Screening for SARS CoV-2 prior to commencement of biologic therapies in patients with Inflammatory Bowel Disease - a potentially harmful practice. DLD. 2020 - PMC - PubMed
    1. Bezzio C., Saibeni S., Variola A., Allocca M., Massari A., Gerardi V. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020;69(7):1213–1217. - PubMed
    1. Brenner E.J., Ungaro R.C., Gearry R.B. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: results From an International Registry. Gastroenterology. 2020 Aug;159(2):481–491.e3. - PMC - PubMed
    1. Zingone F., Buda A., Savarino E.V. Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing? J Crohns Colitis. 2020 May 19:jjaa102. - PMC - PubMed

MeSH terms